OBJECTIVE: To evaluate the impact of two different comorbidity measures on the 6-month mortality of severely ill cancer patients. DESIGN AND SETTING: Prospective cohort study in a ten-bed oncological medical-surgical intensive care unit (ICU). PATIENTS: A total of 772 consecutive patients were included over a 45-month period. The mean age was 57.6+/-16.4 years, and 642 (83%) patients had solid tumors. MEASUREMENTS AND RESULTS: Data were collected on admission and during ICU stay. Comorbidities were evaluated using the Charlson Comorbidity Index (CCI) and the Adult Comorbidity Evaluation (ACE-27). The ICU, hospital, and 6-month mortality rates were 34%, 47%, and 58%, respectively. The most frequent comorbidities were hypertension (33%), diabetes mellitus (8%), and chronic pulmonary disease (7%). There were important differences between the two indices regarding the comorbidity evaluation. Using the ACE-27, 389 patients (50%) had comorbid ailments that were classified as mild (31%), moderate (14%), and severe (5%) according to the comorbidity severity. According to the CCI, 212 patients (27%) had a comorbidity, and their median score was 1 (1-2). In the multivariable Cox proportional hazard models only the presence of a severe comorbidity by the ACE-27 was associated with increased mortality. The CCI was not independently associated with the outcome. Other outcome predictors were older age, poor performance status, active cancer, need of mechanical ventilation, and severity of acute organ failures. CONCLUSIONS: Severe comorbidities must be considered in the outcome evaluation of ICU cancer patients. The ACE-27 seems to be a useful instrument for prognostic assessment in this population.
OBJECTIVE: To evaluate the impact of two different comorbidity measures on the 6-month mortality of severely ill cancerpatients. DESIGN AND SETTING: Prospective cohort study in a ten-bed oncological medical-surgical intensive care unit (ICU). PATIENTS: A total of 772 consecutive patients were included over a 45-month period. The mean age was 57.6+/-16.4 years, and 642 (83%) patients had solid tumors. MEASUREMENTS AND RESULTS: Data were collected on admission and during ICU stay. Comorbidities were evaluated using the Charlson Comorbidity Index (CCI) and the Adult Comorbidity Evaluation (ACE-27). The ICU, hospital, and 6-month mortality rates were 34%, 47%, and 58%, respectively. The most frequent comorbidities were hypertension (33%), diabetes mellitus (8%), and chronic pulmonary disease (7%). There were important differences between the two indices regarding the comorbidity evaluation. Using the ACE-27, 389 patients (50%) had comorbid ailments that were classified as mild (31%), moderate (14%), and severe (5%) according to the comorbidity severity. According to the CCI, 212 patients (27%) had a comorbidity, and their median score was 1 (1-2). In the multivariable Cox proportional hazard models only the presence of a severe comorbidity by the ACE-27 was associated with increased mortality. The CCI was not independently associated with the outcome. Other outcome predictors were older age, poor performance status, active cancer, need of mechanical ventilation, and severity of acute organ failures. CONCLUSIONS: Severe comorbidities must be considered in the outcome evaluation of ICU cancerpatients. The ACE-27 seems to be a useful instrument for prognostic assessment in this population.
Authors: Peter Schellongowski; Michael Benesch; Thomas Lang; Friederike Traunmüller; Christian Zauner; Klaus Laczika; Gottfried J Locker; Michael Frass; Thomas Staudinger Journal: Intensive Care Med Date: 2003-11-04 Impact factor: 17.440
Authors: William L Read; Ryan M Tierney; Nathan C Page; Irene Costas; Ramaswamy Govindan; Edward L J Spitznagel; Jay F Piccirillo Journal: J Clin Oncol Date: 2004-08-01 Impact factor: 44.544
Authors: Dominique D Benoit; Koenraad H Vandewoude; Johan M Decruyenaere; Eric A Hoste; Francis A Colardyn Journal: Crit Care Med Date: 2003-01 Impact factor: 7.598
Authors: Joseph A Johnston; Douglas P Wagner; Stephen Timmons; Deborah Welsh; Joel Tsevat; Marta L Render Journal: Med Care Date: 2002-10 Impact factor: 2.983
Authors: Ralph Simanek; Michael Wuensch; Roland Edlinger; Bernhard Hammerl-Ferrari; Ludwig Kramer; Klaus Geissler Journal: Wien Klin Wochenschr Date: 2010-04 Impact factor: 1.704
Authors: Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerome Pugin; Michael Pinsky; Peter Radermacher; Christian Richard; Robert Tasker Journal: Intensive Care Med Date: 2006-02-17 Impact factor: 17.440
Authors: Huang-Tz Ou; Bhramar Mukherjee; Steven R Erickson; John D Piette; Richard P Bagozzi; Rajesh Balkrishnan Journal: Popul Health Manag Date: 2012-06-25 Impact factor: 2.459
Authors: Robert B Hines; Chakrapani Chatla; Harvey L Bumpers; John W Waterbor; Gerald McGwin; Ellen Funkhouser; Christopher S Coffey; James Posey; Upender Manne Journal: J Clin Oncol Date: 2009-08-03 Impact factor: 44.544